Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca; Daiichi Sankyo; Genomic Health, Inc; Illumina, Inc; Lilly; and Novartis.

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Community Practice Connections™: 3rd Annual International Congress on Oncology & Pathology™

Release Date: August 30, 2019
Expiration Date: August 30, 2020
Media: Internet - based

Activity Overview

Community Practice Connections™: 3rd Annual International Congress on Oncology & Pathology™ is a program featuring brief video interviews with experts in their field exploring questions relevant to community physicians. The interviews are accompanied by focused written summaries pointing out key information relevant to pathologists and oncologists, with a focus on lung, prostate, and bladder cancers.

Benefits of Participating

  • Review high-throughput diagnostic tools
  • Connect molecular profiles to treatment choice
  • Learn status of important biomarkers
  • Hear about updates in staging criteria

Acknowledgement of Commercial Support

This activity is supported by educational grants from AstraZeneca; Daiichi Sankyo; Genomic Health, Inc; Illumina, Inc; Lilly; and Novartis.

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audios/content until you finish the presentation.
  • At the end of the activity, “Educational Content/Audio” will be available for your reference.
  • In order to receive a CME/continuing education (CE) certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational activity is directed toward pathologists and oncologists interested in the management of patients with cancer. Fellows, residents, nurse practitioners, nurses, physician assistants, researchers, and other healthcare professionals interested in the treatment of patients with cancer are also invited to attend.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Assess recent data from clinical studies of biomarkers for commonly encountered malignancies
  • Apply results of tumor pathology assessment to the development of evidence-based treatment approaches
  • Identify multidisciplinary strategies to optimize cancer diagnosis and management
  • Outline the roles of genomic and targeted assays in management of patients with cancer
  • Describe the current status and potential applications of liquid biopsy assessment for commonly encountered malignancies

Faculty, Staff, and Planners’ Disclosures

Faculty

Alain Borczuk
Alain Borczuk, MD
Professor of Pathology and Laboratory Medicine
Vice Chairman, Anatomic Pathology
Department of Pathology and Laboratory Medicine
Weill Cornell Medicine
New York, NY

Disclosures: “Dr. Alan Borczuk” has no relevant financial relationships with commercial interests to disclose.

Balazs Halmos
Balazs Halmos, MD, MS
Professor of Clinical Medicine
Director, Thoracic/Head and Neck Oncology
Director, Clinical Cancer Genomics
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY

Disclosures: Grant Research Support: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Lilly, Merck, Mirati Therapeutics, Novartis, Pfizer, Takeda; Consultant: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, FoundationOne, Genentech, Guardant Health, Novartis, Pfizer, Takeda.

Cristina Magi-Galluzzi
Cristina Magi-Galluzzi, MD, PhD
Professor of Pathology
Division Director, Anatomic Pathology
The University of Alabama at Birmingham
Birmingham, AL

Disclosures: “Dr. Magi-Galluzzi” has no relevant financial relationships with commercial interests to disclose.

The staff of Physicians' Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COIs. PER® has identified and resolved all COIs prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician and nurse relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
Filter By